TY - JOUR
T1 - Human Mutations in the TRPV1 Channel
T2 - Implications for Noxious Cold Sensation
AU - Katz, Ben
AU - Gutorov, Rita
AU - Maayan, Channa
AU - Zaguri, Rachel
AU - Minke, Baruch
PY - 2026/1/1
Y1 - 2026/1/1
N2 - Sensing specific temperature ranges as noxious is crucial for protecting organisms from tissue damage. While the molecular detectors for noxious heat are well-characterized, those responsible for noxious cold detection remain elusive. The transient receptor potential vanilloid 1 (TRPV1) is a polymodal channel activated by heat, acid, and various animal and plant toxins. Due to its association with inflammatory pain, TRPV1 has become a promising target for analgesic development. A recent study reported on an individual carrying a homozygous TRPV1 mutation (N331K) that led to pronounced functional loss. Examination of the affected individual revealed an expected decrease in sensitivity to noxious heat and an unexpected increase in sensitivity to noxious cold. Furthermore, extensive neurogenic inflammatory, flare, and pain responses were observed following the application of a TRPA1 channel activator. These findings suggest that the combined activity of TRPV1 and TRPA1 is essential for controlling noxious cold sensitivity and should be considered when assessing TRPV1 pharmacology.
AB - Sensing specific temperature ranges as noxious is crucial for protecting organisms from tissue damage. While the molecular detectors for noxious heat are well-characterized, those responsible for noxious cold detection remain elusive. The transient receptor potential vanilloid 1 (TRPV1) is a polymodal channel activated by heat, acid, and various animal and plant toxins. Due to its association with inflammatory pain, TRPV1 has become a promising target for analgesic development. A recent study reported on an individual carrying a homozygous TRPV1 mutation (N331K) that led to pronounced functional loss. Examination of the affected individual revealed an expected decrease in sensitivity to noxious heat and an unexpected increase in sensitivity to noxious cold. Furthermore, extensive neurogenic inflammatory, flare, and pain responses were observed following the application of a TRPA1 channel activator. These findings suggest that the combined activity of TRPV1 and TRPA1 is essential for controlling noxious cold sensitivity and should be considered when assessing TRPV1 pharmacology.
KW - TRPA1 channel
KW - ankyrin repeat domain
KW - cold pain
KW - hTRPV1 mutant
KW - inflammatory pain
UR - https://www.scopus.com/pages/publications/105028659221
U2 - 10.1146/annurev-pharmtox-062624-025423
DO - 10.1146/annurev-pharmtox-062624-025423
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 40632671
AN - SCOPUS:105028659221
SN - 0362-1642
VL - 66
SP - 405
EP - 417
JO - Annual Review of Pharmacology and Toxicology
JF - Annual Review of Pharmacology and Toxicology
IS - 1
ER -